Related references
Note: Only part of the references are listed.Immunostimulatory monoclonal antibodies for cancer therapy
Ignacio Melero et al.
NATURE REVIEWS CANCER (2007)
Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting
Ilse Houtenbos et al.
CLINICAL CANCER RESEARCH (2007)
The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells
Lars Fischer et al.
EXPERIMENTAL HEMATOLOGY (2006)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease
J Lee et al.
IMMUNOLOGY LETTERS (2005)
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density
R Niwa et al.
CLINICAL CANCER RESEARCH (2005)
Regulation of dendritic cell function by NK cells: Mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation
PY Pan et al.
JOURNAL OF IMMUNOLOGY (2004)
Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa
A Okazaki et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
CD137-Deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses
DS Vinay et al.
JOURNAL OF IMMUNOLOGY (2004)
Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
4-1BB-mediated immunotherapy of rheumatoid arthritis
SK Seo et al.
NATURE MEDICINE (2004)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes
KM Kim et al.
IMMUNOLOGY (2002)
Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity
RA Wilcox et al.
JOURNAL OF IMMUNOLOGY (2002)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
RA Wilcox et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: Long-term remission of liver metastases in a mouse model
O Martinet et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
